Global Eye Drug Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Eye Drug Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Eye Drug Market Size Growth Rate by Product
  • 1.4.2 Drops
  • 1.4.3 Tablet & Capsule
• 1.5 Market by End User
  • 1.5.1 Global Eye Drug Market Size Growth Rate by End User
  • 1.5.2 Glaucoma
  • 1.5.3 Retinal Disease
  • 1.5.4 Bacterial?Infection
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Eye Drug Market Size
  • 2.1.1 Global Eye Drug Revenue 2014-2025
  • 2.1.2 Global Eye Drug Sales 2014-2025
• 2.2 Eye Drug Growth Rate by Regions
  • 2.2.1 Global Eye Drug Sales by Regions
  • 2.2.2 Global Eye Drug Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Eye Drug Sales by Manufacturers
  • 3.1.1 Eye Drug Sales by Manufacturers
  • 3.1.2 Eye Drug Sales Market Share by Manufacturers
  • 3.1.3 Global Eye Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Eye Drug Revenue by Manufacturers
  • 3.2.1 Eye Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Eye Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 Eye Drug Price by Manufacturers
• 3.4 Eye Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Eye Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Eye Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Eye Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Eye Drug Sales by Product
• 4.2 Global Eye Drug Revenue by Product
• 4.3 Eye Drug Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Eye Drug Breakdown Data by End User

6 North America

• 6.1 North America Eye Drug by Countries
  • 6.1.1 North America Eye Drug Sales by Countries
  • 6.1.2 North America Eye Drug Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Eye Drug by Product
• 6.3 North America Eye Drug by End User

7 Europe

• 7.1 Europe Eye Drug by Countries
  • 7.1.1 Europe Eye Drug Sales by Countries
  • 7.1.2 Europe Eye Drug Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Eye Drug by Product
• 7.3 Europe Eye Drug by End User

8 Asia Pacific

• 8.1 Asia Pacific Eye Drug by Countries
  • 8.1.1 Asia Pacific Eye Drug Sales by Countries
  • 8.1.2 Asia Pacific Eye Drug Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Eye Drug by Product
• 8.3 Asia Pacific Eye Drug by End User

9 Central & South America

• 9.1 Central & South America Eye Drug by Countries
  • 9.1.1 Central & South America Eye Drug Sales by Countries
  • 9.1.2 Central & South America Eye Drug Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Eye Drug by Product
• 9.3 Central & South America Eye Drug by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Eye Drug by Countries
  • 10.1.1 Middle East and Africa Eye Drug Sales by Countries
  • 10.1.2 Middle East and Africa Eye Drug Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Eye Drug by Product
• 10.3 Middle East and Africa Eye Drug by End User

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Eye Drug Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis Eye Drug Products Offered
  • 11.2.5 Novartis Recent Development
• 11.3 bausch Lomb
  • 11.3.1 bausch Lomb Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 bausch Lomb Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 bausch Lomb Eye Drug Products Offered
  • 11.3.5 bausch Lomb Recent Development
• 11.4 Laboratoire Riva
  • 11.4.1 Laboratoire Riva Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Laboratoire Riva Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Laboratoire Riva Eye Drug Products Offered
  • 11.4.5 Laboratoire Riva Recent Development
• 11.5 Jamp Pharma
  • 11.5.1 Jamp Pharma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Jamp Pharma Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Jamp Pharma Eye Drug Products Offered
  • 11.5.5 Jamp Pharma Recent Development
• 11.6 Fresenius
  • 11.6.1 Fresenius Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Fresenius Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Fresenius Eye Drug Products Offered
  • 11.6.5 Fresenius Recent Development
• 11.7 Teva Pharmaceutical?
  • 11.7.1 Teva Pharmaceutical? Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Teva Pharmaceutical? Eye Drug Products Offered
  • 11.7.5 Teva Pharmaceutical? Recent Development
• 11.8 SANDOZ
  • 11.8.1 SANDOZ Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 SANDOZ Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 SANDOZ Eye Drug Products Offered
  • 11.8.5 SANDOZ Recent Development
• 11.9 Greenstone
  • 11.9.1 Greenstone Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Greenstone Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Greenstone Eye Drug Products Offered
  • 11.9.5 Greenstone Recent Development
• 11.10 Mylan
  • 11.10.1 Mylan Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Mylan Eye Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Mylan Eye Drug Products Offered
  • 11.10.5 Mylan Recent Development
• 11.11 GE Medical
• 11.12 Mint Pharmaceuticals
• 11.13 Laboratoires Thea
• 11.14 Taj Pharmaceuticals
• 11.15 Actavis
• 11.16 APOTEX
• 11.17 Sun Pharma

12 Future Forecast

• 12.1 Eye Drug Market Forecast by Regions
  • 12.1.1 Global Eye Drug Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Eye Drug Revenue Forecast by Regions 2019-2025
• 12.2 Eye Drug Market Forecast by Product
  • 12.2.1 Global Eye Drug Sales Forecast by Product 2019-2025
  • 12.2.2 Global Eye Drug Revenue Forecast by Product 2019-2025
• 12.3 Eye Drug Market Forecast by End User
• 12.4 North America Eye Drug Forecast
• 12.5 Europe Eye Drug Forecast
• 12.6 Asia Pacific Eye Drug Forecast
• 12.7 Central & South America Eye Drug Forecast
• 12.8 Middle East and Africa Eye Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Eye Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details